Hospital
Hillcrest Baptist Medical Center
Hillcrest Baptist Medical Center was paid $14.28M by Medicaid between Oct 2020 and Dec 2024, across 113 billing codes. Its largest line is 99284, emergency room visit (serious) — 53% of everything it billed.
33Billing provider infoHILLCREST BAPTIST MEDICAL CENTER
WACO, TX 76712
WACO, TX 76712
33aNPI1891882833assigned 10/10/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$14.28M
24GClaims263,629
24DCodes billed113
24AFirst – last monthOct 2020 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Texas
Rank by total paid#11 of 109
Median peer was paid$1.15M
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 4,251 | $237K | |
| 2021 | 72,166 | $3.31M | |
| 2022 | 74,393 | $4.13M | |
| 2023 | 77,397 | $4.59M | |
| 2024incomplete | 35,422 | $2.02M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 53% | 22,622 | 21,284 | $7.58M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13% | 4,778 | 4,471 | $1.89M |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 6.1% | 14,481 | 13,837 | $866K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 4.9% | 15,786 | 14,816 | $693K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.6% | 7,235 | 6,593 | $369K |
| 71045 | Radiologic examination, chest; single view | 2.5% | 11,225 | 10,482 | $357K |
| 80053 | Comprehensive metabolic panel | 2.1% | 25,879 | 22,801 | $303K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.9% | 6,361 | 6,019 | $273K |
| 59025 | Fetal non-stress test | 1.8% | 1,808 | 1,427 | $250K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.6% | 27,170 | 23,794 | $228K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.5% | 13,142 | 12,543 | $217K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 1.5% | 76 | 75 | $212K |
101 more codes
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 1.4% | 13,813 | $200K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 171 | $90K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,025 | $82K |
| 42830 | <1% | 44 | $58K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,059 | $55K |
| 81001 | <1% | 15,909 | $54K | |
| 84702 | <1% | 5,216 | $52K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,280 | $50K |
| 83690 | <1% | 6,582 | $39K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,391 | $30K |
| 84112 | <1% | 230 | $30K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,019 | $21K |
| 84484 | <1% | 3,472 | $21K | |
| 93975 | <1% | 149 | $20K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 373 | $18K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 358 | $15K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 502 | $14K |
| 86850 | <1% | 932 | $14K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 448 | $13K |
| 36415 | Collection of venous blood by venipuncture | <1% | 23,205 | $12K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 24 | $9K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 851 | $8K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,472 | $8K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 143 | $8K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 753 | $8K |
| 84703 | <1% | 1,218 | $7K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 453 | $6K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 89 | $6K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 287 | $5K |
| 83880 | <1% | 1,021 | $4K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 757 | $4K |
| 84145 | <1% | 469 | $4K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 72 | $3K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 270 | $3K |
| 83605 | <1% | 1,148 | $3K | |
| 87653 | <1% | 81 | $3K | |
| 85027 | <1% | 394 | $3K | |
| 86900 | <1% | 1,232 | $3K | |
| 86901 | <1% | 1,230 | $3K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 186 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 632 | $2K |
| 87081 | <1% | 241 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 359 | $2K |
| 86592 | <1% | 381 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 44 | $2K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,736 | $2K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,112 | $2K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 12 | $2K |
| 86780 | <1% | 98 | $2K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 88 | $1K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 14 | $1K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,420 | $1K |
| 85610 | <1% | 1,067 | $1K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 17 | $1K |
| 36416 | <1% | 612 | $1K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 21 | $1K |
| 83735 | <1% | 779 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 43 | $1K |
| 80061 | Lipid panel | <1% | 54 | $1K |
| 76801 | <1% | 14 | $1K | |
| 85730 | <1% | 624 | $1K | |
| 0001A | <1% | 225 | $1K | |
| 87210 | <1% | 114 | $957.32 | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 45 | $920.16 |
| 0002A | <1% | 215 | $818.96 | |
| 0071A | <1% | 54 | $677.79 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 825 | $644.50 |
| 86140 | <1% | 263 | $518.24 | |
| 82950 | <1% | 79 | $479.48 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 165 | $479.36 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 13 | $466.11 |
| 96160 | <1% | 65 | $463.76 | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 29 | $450.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 365 | $431.21 |
| 87340 | <1% | 26 | $425.16 | |
| 86803 | <1% | 28 | $396.94 | |
| 82803 | <1% | 104 | $348.22 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 15 | $328.91 |
| 0072A | <1% | 28 | $317.87 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 961 | $306.21 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 678 | $294.61 |
| 86762 | <1% | 12 | $287.75 | |
| 94760 | <1% | 35 | $257.34 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 14 | $182.62 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 460 | $180.18 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 12 | $154.32 |
| 82570 | <1% | 14 | $129.81 | |
| 84156 | <1% | 15 | $91.89 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 17 | $72.00 |
| 85007 | <1% | 38 | $66.99 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 30 | $63.19 |
| 81003 | <1% | 55 | $62.28 | |
| 87186 | <1% | 33 | $29.08 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 142 | $24.97 |
| 96161 | <1% | 201 | $18.28 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 65 | $14.33 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 36 | $12.86 |
| 82962 | <1% | 782 | $7.78 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 12 | $3.84 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 3,868 | $0.03 |
| J2704 | Injection, propofol, 10 mg | 0% | 232 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMACH, SHELLIE (CFO)
| Provider | Location | Paid |
|---|---|---|
| Hillcrest Family Health Center | Waco, TX | $2.20M |
| Hillcrest Physician Services | Waco, TX | $1.53M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.